Funding opportunities and RFIs to support research relating to COVID-19 from various agencies/organizations are listed below; please note that this list is not exhaustive. The list will be updated Mondays, Wednesdays, and Fridays by 5 pm. Please contact?[email protected]?to add a funding opportunity or with any questions.

Proposals for critical continuing laboratory research that could impact the diagnosis or treatment of COVID-19 in the current crisis should be sent to?[email protected]?for review and approval.

Title
Agency
Amount
Deadlines
Discipline
Description
Posted Date

NIH
Not specified
6/19/20

Biomedical, Clinical Research, Public Health, Social Sciences

In order to rapidly improve the understanding, diagnosis, and treatment of COVID-19, OSC is encouraging the submission of innovative applications for Emergency Competitive Revisions to active eligible?Common Fund grants and cooperative agreements. Innovation may be technological or conceptual. Any relevant area of innovative research is welcome, including behavioral/social science research, research on health disparities, novel therapeutics, and other related topics.

NIH
$275,000 (up to two-years)
rolling

Biomedical, Public Health

The purpose of this FOA?is to provide an expedited funding mechanism for research to better understand SARS-CoV-2/COVID-19, particularly to improve understanding of fundamental virology, immunology, and the development of animal models, reagents, and medical countermeasures and to share findings quickly and broadly.?R21 Exploratory/Developmental Research Grant mechanism.? Companion - R01 PAR-20-178.

NIH
Not specified; project period up to five years
rolling

Biomedical, Public Health

The purpose of this FOA is to provide an expedited funding mechanism for research to better understand SARS-CoV-2/COVID-19, particularly to improve understanding of fundamental virology, immunology, and the development of animal models, reagents, and medical countermeasures and to share findings quickly and broadly. R01 Research Project Grant - preliminary data and/or planning to include longitudinal analysis?companion - for high-risk/high-payoff lacking preliminary data see?R21 PAR-20-177.

NIH
Award budget is contingent upon mechanism type. Please note that some mechanisms have DIRECT cost dollar limits and some have TOTAL cost dollar limits. Please see FOA.
5/29/20

Biomedical, Clinical Research, Public Health

The Agency for Healthcare Research and Quality (AHRQ) hereby notifies grantees holding active AHRQ awards, (except R13s, T32s, F32s), that funds are available for competitive revisions to meet immediate needs to help address timely health system and healthcare professional response to the COVID-19 public health crisis. This FOA does not include grants that were previously funded under FOAs supported by Patient Centered Outcome Research Trust Fund (PCOR TF) dollars (Please see FOA number PA-20-072, which is directed towards those grants).

NIH
Award budget is contingent upon mechanism type. Please note that some mechanisms have DIRECT cost dollar limits and some have TOTAL cost dollar limits. Please see FOA.
5/29

Biomedical, Clinical Research, Public Health

Grantees holding active AHRQ awards that were funded under the PCOR FOAs, (see above: Part 1. Overview Information, Activity Code list), that funds are available for competitive revisions to meet immediate needs to help address timely health system and healthcare professional response to the COVID-19 public health crisis. This FOA does not include grants that were awarded using AHRQ Health Service Research (HSR) dollars (please see FOA number PA-20-070, which is directed toward those grants).
?

NIH
Diversion of funds with NCI approval
rolling

Biomedical, Clinical Research, Public Health

NCI anticipates that in infrequent cases, NCI-funded investigators will have novel insights and research proposals of immediate relevance to SARS-CoV-2 and COVID-19. In those cases, but only for the duration of the present crisis, NCI would consider requests from its funded grantees and cooperative agreement awardees to engage in limited COVID-19 related research using part of their existing NCI-funded resources.

NIH
$275,000 (up to two-years)
6/16/20

Biomedical, Clinical Research, Public Health, Computation

Apply via PA-19-053. In order to rapidly improve our understanding of the infection of SARS-CoV-2 and of COVID-19, ?applications are expected to focus on informatics and data science methods to help address the COVID-19 pandemic in a timely manner.

DoE
Remote Access, in-kind Lab labor; not a monetary grant
rolling

Biomedical, Clinical Research

Oak Ridge National Laboratory (ORNL) is currently restricting site access. Rapid Access proposals will be performed as remote access experiments with limited internal staff. The Department of Energy Basic Energy Sciences advanced neutron sources will provide remote rapid access to advanced user facilities to support research into the COVID-19 virus and the search for effective diagnostics and therapies. Facilities that will be made available at the Spallation Neutron Source (SNS) and High Flux Isotope Reactor (HFIR) at ORNL , include neutron macromolecular crystallography, small-angle scattering, reflectometry, spectroscopy and imaging beamlines.

Private/Foundations
$20,000
5/11/20

Social Sciences, Public Health

The National Bureau of Economic Research (NBER) is offering approximately four research grants of $20,000 each to support projects related to women, victimization, and domestic violence, with particular emphasis on the impact of the current COVID-19 pandemic.

Private/Foundations
n/a
rolling

Technology development, Biomedical, Computation, Engineering, Physical Sciences, Social Sciences, Public Health, Humanities

The Mercatus Center at George Mason University, building on its COVID-19 policy brief series, welcomes proposals for policy briefs, working papers, and articles that address the next round of challenges facing the United States and other countries in the response to the pandemic.

Private/Foundations
up to $100,000
6/5/20

Technology development, Biomedical, Computation, Engineering, Physical Sciences, Social Sciences, Public Health, Humanities

The Booz Allen Foundation has established a $1 million Innovation to surface the best solutions for addressing the social issues created by COVID-19 and empower the people and organizations behind those solutions to drive their development and implementation. The Foundation is specifically interested in solutions and projects that will build lasting community resilience through protecting vulnerable populations and frontline workers or providing for the safe return to work.

Private/Foundations
~1000 EURO per project (dependent on exchange rates)
5/15/20

Technology development, Biomedical, Computation, Engineering, Physical Sciences, Public Health

In recognition of the seriousness of this situation, and the urgency for action, the OAD hereby releases an extraordinary, fast-tracked call for proposals for projects (or partnerships) that in some way use astronomy, in any of its aspects (including skills, methodologies, tools, infrastructure, inspiration or even just networks of astronomers/enthusiasts themselves) to help mitigate some of the negative effects of the pandemic.

Private/Foundations
$5,000 to $25,000; over one year
6/1/20

Biomedical, Clinical Research

In order to apply, you must be a member of Society for Academic Emergency Medicine (SAEMF)?in good standing at the application deadline and during the entire award period. The purpose of this award is to support emergency care research related to COVID-19, which may include diagnostics, safety, therapeutics, disaster preparedness, or other relevant topic areas.?

Private/Foundations
$2,000 to $5,000, with the possibility of slightly more support for collaborative projects of two or more researchers.
6/1/20

Social Sciences

The Social Science Research Council (SSRC), as part of its Covid-19 Initiative, seeks proposals from across the social sciences and related fields that address the social, economic, cultural, psychological, and political impact of Covid-19 in the United States and globally, as well as responses to the pandemic’s wide-ranging effects.

NIH
up to $25,000 in start up costs, then grants of $500,000+
Rolling; submit ASAP

Biomedical, Technology development

Support to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2

NIH
Not specified
6/20/20

Biomedical, Clinical Research, Public Health, Social Sciences

This NIH Common Fund CARES Act funding seeks proposals to rapidly improve the understanding, diagnosis, and treatment of COVID-19 via innovative applications for Emergency Competitive Revisions to active Common Fund grants and cooperative agreements. Innovation may be technological or conceptual. Any relevant area of innovative research is welcome, including behavioral/social science research, research on health disparities, novel therapeutics, and other related topics.

Private/Foundations
Up to $100,000
6/5/20

Biomedical, Clinical Research, Public Health

Grants to conduct research that will provide high-impact new knowledge to advance emergency patient care, improve response of hospitals/healthcare and EMS systems, and protect emergency medicine healthcare professionals during pandemics

Private/Foundations
up to $200,000
5/30/20

Biomedical, Clinical Research, Public Health, Social Sciences

Projects are sought that address any of the following: basic biology that could lead to better treatment and prevention; novel therapeutics and vaccines; host factors that alter response to these infections; community spread; case tracking and epidemiological approaches

NIH
Up to $75,000
6/1/20

Data Science

Administrative supplements to active NLM R01 grants to focus on informatics and data science methods to help address the COVID-19 pandemic in a timely manner. Apply via PA-18-591.

NIH
Up to $100,000 direct costs per year
4/15/21

Biomedical, Clinical Research, Public Health

Urgent competitive revisions and administrative supplements to existing grants to assess the impact of alcohol as a biological contributor to COVID-19 outcomes, to assess behavioral, social, and economic consequences of the pandemic and to assess the responses that the pandemic has provoked as they relate to alcohol consumption and related outcomes. Apply via PA-18-935 or PA-18-591.

NIH
up to $50,000
Rolling

Public Health, Clinical Research

PCORI is offering enhancements to existing research awards to address the COVID-19 crisis (e.g., prevention, diagnosis, treatment, supply of critical resources, and health system adaptations including telemedicine, community outreach especially to vulnerable populations)

NIH
Up to $100,000 direct costs per year
3/31/21

Public Health, Social Sciences

Competitive and administrative supplements to existing longitudinal studies that address key social, behavioral, economic, health communication, and epidemiologic research questions relevant to the 2019 Novel Coronavirus (SARS-CoV-2) and COVID-19. Apply via PA-18-935 or PA-18-591.

Private/Foundations
$20,000 to $250,000
5/22/20

Biomedical, Public Health, Clinical Research

Support for educational programs for healthcare providers focused on the recognition, diagnosis, treatment, and overall care management of patients with COVID-19, as well as provide support to hospitals or healthcare systems so that they may evaluate and improve their systems-of-care for COVID-19 patients

NIH
Not specified
11/10/20

Biomedical, Technology development

Development, translation, and commercialization of technologies to address COVID-19; develop life-saving technologies that can be ready for commercialization within one to two years. Apply via PA-20-135 or PA-18-591.

NIH
Not specified
6/5/20 & 6/16/20; varies by program

Biomedical, Technology development

Development, translation, and commercialization of technologies to address COVID-19; develop life-saving technologies that can be ready for commercialization within one to two years

NIH
up to $100,000 in direct costs
6/25/20

Biomedical, Clinical Research

Understanding the basic mechanisms of interaction between SARS-CoV-2 and cancer cells, co-morbidities of cancer and SARS-CoV-2 infection, and the impacts on treatment and clinical outcomes of SARS-CoV-2 infected persons in the context of cancer. Apply via PA-18-591 or PA-18-935.

NIH
Not specified
10/6/20

Biomedical, Clinical Research

Research on stress management strategies, including mind and body approaches, that individuals may engage in remotely to address stressors related to social distancing, as well as to address recovery and recurrence of symptoms during and after COVID-19 infections. Apply via PA-18-591 or PA-18-935.

NIH
Not specified
Not yet announced

Public Health

AHRQ grantees (R01, R03, R18, K12, U01, U18) may soon be eligible for competitive revision funding to meet immediate needs to help address timely health system and healthcare professional response to the COVID-19

NIH
Not specified
Not yet announced

Public Health

AHRQ is particularly interested in understanding how digital health innovations contributed to health system and healthcare professional innovation and challenges and solutions to meeting the needs of vulnerable populations including older adults, people living with multiple chronic conditions, rural communities, and uninsured and underinsured populations

NIH
Not specified
4/15/21

Biomedical, Public Health, Clinical Research

Strengthen the mental health response to COVID-19 and to future public health emergencies; research addressing the intersection of COVID-19, mental health, and HIV treatment and prevention. Apply via PA-18-935 or PA-18-591.

NIH
up to $125,000 in direct costs
5/1/21

Public Health

Impact of the novel Coronavirus pandemic causing COVID-19 disease outbreaks and the resulting disruptions on individual and social wellbeing, health services use, and health outcomes for NIH-designated health disparity populations. Apply via PA-18-935 or PA-18-591.

NIH
Not specified
5/3/21

Biomedical, Public Health

Impact of environmental exposures on COVID-19; the role of environmental exposures in pathogenicity, transmission, individual susceptibility, or prevention and intervention strategies. Apply via PA-20-135.

NIH
up to $500,000 in direct costs
6/1/20

Biomedical, Clinical Research

Studies to elucidate if COVID-19 might provoke or exacerbate noncommunicable gastrointestinal, liver, kidney/urological and metabolic/endocrine diseases in people with HIV (PWH) or worsen the consequences of viral hepatitis coinfection; whether PWH and NIDDK related comorbidities, coinfections, and complications have different COVID-19 outcomes. Apply via PA-18-935.

NIH
up to $500,000 in direct costs
6/1/20

Biomedical, Clinical Research

The direct action of the COVID-19 on kidney, gastrointestinal tract function, and the endocrine/metabolic system. Apply via PA-18-935.

NIH
up to $125,000 in direct costs
6/1/20

Public Health, Clinical Research

Pathology, prevention, diagnosis, sequelae, or treatment of COVID-19 directly related to NIDCD’s mission areas. Apply via PA-18-591 or PA-18-935.

DoD
up to $6 M total
Pre-Applications: 6/8/20; Applications: 6/22/20

Biomedical, Clinical Research, Public Health

Diagnostics, antibody identification, predictive modeling tools, threat mitigation, triage of care, molecular and biological mechanisms of COVID-19 health impacts, biomarkers, etiology and prevention of acute respiratory distress syndrome (ARDS), therapeutics. Military relevance must be addressed

DoD
up to $2 M total
Pre-Applications: 5/28/20; Applications: 6/12/20

Biomedical, Clinical Research, Public Health

Diagnostics, antibody identification, predictive modeling tools, threat mitigation, triage of care, molecular and biological mechanisms of COVID-19 health impacts, biomarkers, etiology and prevention of acute respiratory distress syndrome (ARDS), therapeutics. Military relevance must be addressed

DoD
up to $4 M total
Pre-Applications: 5/28/20; Applications: 6/12/20

Biomedical, Clinical Research, Public Health

Diagnostics, antibody identification, predictive modeling tools, threat mitigation, triage of care, molecular and biological mechanisms of COVID-19 health impacts, biomarkers, etiology and prevention of acute respiratory distress syndrome (ARDS), therapeutics. Military relevance must be addressed

Private/Foundations
up to $175,000
5/21/20 for letters of inquiry

Public Health, Social Sciences

Research analyzing social, political, economic, or psychological disruptions resulting from the coronavirus crisis that affect social and living conditions in the United States

Private/Foundations
$150,000+
4/30/20

Biomedical, Clinical Research

?

Novel therapies, broad-spectrum anti-viral therapies, next generation vaccines, emergency countermeasures/prophylaxis strategies for first responders and emergency medical personnel

Private/Foundations
$10,000 to $500,000
Rolling

Biomedical, Clinical Research, Technology development, Public Health

6 months of funding for COVID-19 related projects; funding decisions are made in under 48 hours

DoD
Not specified
9/30/20

Biomedical, Technology development

Innovative technologies that propose new solutions and/or potentially new capabilities in support of the COVID-19 Response Acquisition Task Force (DAF ACT) mission to provide relief, resilience, recovery, and stability to the nation in response to the COVID-19 pandemic

DoD
$100,000
Rolling

Biomedical, Technology development

Low-cost, readily manufacturable emergency ventilator models to quickly augment ventilator capacity in the exigent COVID-19 pandemic

Private/Foundations
$50,000-$100,000
5/20/20

Social Sciences

Facebook is interested in supporting projects that address the economic consequences and implications of developing digital technologies for small businesses. Topics of interest include measuring new types of economic impact, assessing the implications of digital technologies for growth, resilience under challenging circumstances, inclusion of marginalized groups, and efficiency of payment systems

Private/Foundations
n/a
Rolling

Computation

Access to varied computing capabilities to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections

NIH
Not specified
5/1/21

Biomedical, Public Health

NIA & NIMH are offering Supplements & Revisions to certain active grants. NIA: improve prevention of disease transmission among older adults and mitigation of disease severity and mortality in older adults with COVID-19. NIMH: examine how a disrupted workforce may adequately respond/adapt to and maintain services or provide additional care for new or worsening mental health needs and/or suicide risk in midlife and older age adults. Apply via PA-18-935 or PA-18-591.

NIH
Not specified
4/9/20

Biomedical, Clinical Research, Technology development

Division of Microbiology and Infectious Diseases research areas applicable to COVID-19 research:?Research Area 003?- Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases.?Research Area 004?- Development of Therapeutic Products for Biodefense, Anti-Microbial Resistant (AMR) Infections and Emerging Infectious Diseases.?Research Area 005?- Advanced Development of Diagnostics for Biothreats and Emerging Infectious Diseases

Private/Foundations
Not specified
5/1/20 (round 1); 5/27/20 (round 2-by invitation only)

Biomedical, Technology development

Innovations for a rapidly deployable, minimum viable mechanical ventilator for patients with COVID-19 related ventilator-dependent lung injury

NIH
up to $250,000 per year in direct costs
5/15/50

Biomedical

Genomic research on SARS-CoV-2 and COVID-19 disease; genomic studies utilizing generalized approaches that take advantage of human research or model systems to study the consequences of SARS-CoV-2 infection. Apply via PA-18-935 or PA-18-591.

Private/Foundations
$40,000
4/30/20

Biomedical, Clinical Research, Public Health, Computation

From The Johns Hopkins Center for Alternatives to Animal Testing (CAAT): projects to help accelerate the discovery of mechanisms, medicines and vaccines for coronaviruses; development of non-animal, human biology-based models to help coordinate and accelerate response to emerging pandemics in the future

Private/Foundations
up to $50,000
Rolling

Computation

Open source technology projects which are responding to the COVID-19 pandemic in some way. Includes hardware, software, as well as software that solves for secondary effects of COVID-19

DoD
$37 M (total program funding)
Enhanced White Papers due 4/30/20

Biomedical, Computation, Technology development

Health information management system for “virtual critical care wards.” Mobile communications capabilities, web portal and/or appl, real-time documentation capabilities, cloud-based information storage, IoT, artificial intelligence

NIH
Not specified
4/5/20; varies by program

Biomedical, Public Health

NIAID is offering Competitive Revisions to active grants and funding for new projects. Viral natural history, pathogenicity, transmission, medical countermeasures, animal models, pre-clinical testing of vaccines and therapeutics

NIH
Not specified
6/5/20, 6/16/20, 6/26/20; varies by program

Biomedical, Clinical Research

Repurposing of existing drugs or biologics, Phase I clinical trials. Apply via?PAR-17-465,?PAR-18-462, or?PAR-18-332.

Private/Foundations
$20 M total in Google Cloud credits
Rolling

Computation

Google is offering Google Cloud credits for researchers to leverage their computing capabilities and infrastructure as they study potential therapies and vaccines, track critical data, and identify new ways to combat COVID-19

NIH
Not specified
Not yet announced

Public Health

In early May, AHRQ intends to publish a new funding opportunity announcement to support evaluations of health system and healthcare professional responsiveness to COVID-19. Topics: telemedicine, health system response to COVID-19, the role of primary care practices and professionals during the COVID-19 epidemic, digital health innovations, vulnerable populations. Current AHRQ grantees should also see NOT-HS-20-007.

NIH
Not specified
3/25/21

Biomedical

NIAID is offering Competitive Revisions to active grants. Viral natural history, pathogenicity, transmission, medical countermeasures, animal models, pre-clinical testing of vaccines and therapeutics. Apply via PA-20-135.

NSF
Not specified
rolling

Technology development, Biomedical, Physical Sciences, Computation, Engineering

Artificial intelligence, digital health, diagnostics, distributed ledger, environmental technologies, medical devices, pharmaceutical technologies, disinfection and sterilization, filtration and separations

NIH
Not specified
5/4/20, 7/10/20; varies by program

Biomedical, Public Health

NCATS is offering Supplements to certain active grants to study the use of informatics solutions to diagnose cases and the use of CTSA-supported core resources to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics, and vaccines

Private/Foundations
up to $100,000
4/6/20

Biomedical

Understanding the cardiovascular and cerebrovascular pathogenesis, diagnosis, prevention, clinical manifestations, clinical management (including critical care management) and social behaviors which can lead to dissemination, containment, and complications of COVID-19

Private/Foundations
10 M GBP (total program funding)
4/6/20

Biomedical

Clinical research, Drug Development, Therapeutics

Private/Foundations
$20 M total in Amazon Web Services in-kind credits and technical support
Rolling

Computation

Support for innovation in rapid and accurate patient testing for 2019 novel coronavirus (COVID-19), and other diagnostic solutions to mitigate future outbreaks

NIH
Up to $100,000 direct costs per year
3/31/21

Biomedical, Public Health

Research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders. Apply via PA-18-935 or PA-18-591.

DoD
Not specified
Rolling

Biomedical, Clinical Research, Technology development

The U.S. government is providing a portal for the 2019 novel coronavirus (COVID-19) medical countermeasures task force as a single point of entry for the submission of ideas and information regarding diagnostics, therapeutics, vaccines, and other products or technologies relevant to addressing this outbreak.

DoD
Not specified
Rolling

Technology development, Biomedical, Engineering

The DARPA technical offices that are focused on COVID-19 efforts are the Defense Sciences Office (DSO) and the Biological Technology Office (BTO), both of which have Office-Wide Broad Agency Announcements (BAA) that are open for the submission of new ideas at any time.

NIH
Not specified
10/6/20

Biomedical

Host response, associations with heart/lung/blood (HLB) diseases, potential impacts on transfusion safety, clinical outcomes of infected individuals. Apply via PA-18-935 or PA-18-591.

Private/Foundations
Not specified
5/4/20

Public Health, International Health

COVID-19 response in humanitarian settings: Innovative solutions, Supporting existing health care delivery, Predicting outbreaks, Social science behavioural research, Co-ordination and sharing

Private/Foundations
n/a
Rolling

Computation, Physical Sciences

Announcing the availability of COVID-19 datasets; new text and data mining techniques sought to help the science community use COVID-19 research data

DoD
Not specified
Enhanced White Papers due 4/15/20

Biomedical, Computation, Technology development

Point-of-care diagnostics, Prophylactic(s)/Therapeutic(s), Disease predictive modeling that may include social media and artificial intelligence (AI) parameter decision tools, Patient monitoring/tracking/management system for in-home or non-hospital environment, patient tele-health services

DoE
N/A
Rolling

Computation, Facilities, Physical Sciences

Ideas to leverage DOE user facilities, computational resources, and infrastructure to assist with the COVID-19 response

CDC
$10 M (total funding available)
White papers due by 3:00PM EST on 3/25/20

Biomedical, Public Health

Transmission, Diagnostics development, Immune response, Antibody production, small animal model development, identify biomarkers

NIH
up to $750,000 direct costs per year
6/29/20

Biomedical

Preclinical development of lead candidate therapeutics/vaccines/related countermeasures, Emerging Infectious Diseases/Pathogens, Product Development Strategy, collaboration with industry

DoD
up to $750,000
Abstracts due by 6/30/20

Biomedical, Devices

Molecular Diagnostic Assays, Nonclinical Model Development, COVID-19 Vaccine, Advanced Manufacturing Technologies

DoD
Not specified
White papers due by 10/31/20

Biomedical, Devices

Diagnostic assays, COVID-19 Vaccine, COVID-19 Therapeutics, Immunomodulators or therapeutics targeting lung repair, Pre-exposure and post-exposure prophylaxis, Respiratory protective devices, Ventilators, Advanced Manufacturing Technologies

Private/Foundations
up to 250,000 €/year for 3 years
8/31/20

Technology development, Biomedical, Computation, Engineering, Physical Sciences

From Merck KGaA, Darmstadt, Germany: research grants for technological solutions towards pandemic outbreak preparedness or solutions that could help fighting emerging viral infections

Private/Foundations
$10,000
6/18/20

Technology development, Biomedical, Computation, Physical Sciences

Tech innovations that can slow and track the spread of an emerging outbreak (for example by improving individual hygiene, developing low-cost rapid diagnostics, analyzing data that informs decision making, providing tools that support and protect health workers)

NSF
Up to $200,000
Rolling

Computation, Biological Sciences, Physical Sciences, Social Sciences

Non-medical and non-clinical-care research, modeling understanding the spread of COVID-19, virus transmission and prevention, processes and actions to address this global challenge. Apply through existing funding opportunities and use the Rapid Response Research (RAPID) funding mechanism.

NIH
Not specified
2/6/21

Biomedical, Public Health

NIGMS is offering Competitive Revisions to active grants. 2019-nCoV data, develop predictive models for the spread of Coronaviruses and related pathogens. Apply via PA-18-935.